COVID-19: Histopathological correlates of imaging patterns on chest computed tomography.

COVID-19 SARS-CoV-2, viral infection acute respiratory distress syndrome chest CT coronavirus disease histopathological and imaging

Journal

Respirology (Carlton, Vic.)
ISSN: 1440-1843
Titre abrégé: Respirology
Pays: Australia
ID NLM: 9616368

Informations de publication

Date de publication:
09 2021
Historique:
revised: 22 04 2021
received: 02 02 2021
accepted: 02 06 2021
pubmed: 24 6 2021
medline: 8 10 2021
entrez: 23 6 2021
Statut: ppublish

Résumé

Patients with coronavirus disease 2019 (COVID-19) pneumonia present with typical findings on chest computed tomography (CT), but the underlying histopathological patterns are unknown. Through direct regional correlation of imaging findings to histopathological patterns, this study aimed to explain typical COVID-19 CT patterns at tissue level. Eight autopsy cases were prospectively selected of patients with PCR-proven COVID-19 pneumonia with varying clinical manifestations and causes of death. All had been subjected to chest CT imaging 24-72 h prior to death. Twenty-seven lung areas with typical COVID-19 patterns and two radiologically unaffected pulmonary areas were correlated to histopathological findings in the same lung regions. Two dominant radiological patterns were observed: ground-glass opacity (GGO) (n = 11) and consolidation (n = 16). In seven of 11 sampled areas of GGO, diffuse alveolar damage (DAD) was observed. In four areas of GGO, the histological pattern was vascular damage and thrombosis, with (n = 2) or without DAD (n = 2). DAD was also observed in five of 16 samples derived from areas of radiological consolidation. Seven areas of consolidation were based on a combination of DAD, vascular damage and thrombosis. In four areas of consolidation, bronchopneumonia was found. Unexpectedly, in samples from radiologically unaffected lung parenchyma, evidence was found of vascular damage and thrombosis. In COVID-19, radiological findings of GGO and consolidation are mostly explained by DAD or a combination of DAD and vascular damage plus thrombosis. However, the different typical CT patterns in COVID-19 are not related to specific histopathological patterns. Microvascular damage and thrombosis are even encountered in the radiologically normal lung.

Sections du résumé

BACKGROUND AND OBJECTIVE
Patients with coronavirus disease 2019 (COVID-19) pneumonia present with typical findings on chest computed tomography (CT), but the underlying histopathological patterns are unknown. Through direct regional correlation of imaging findings to histopathological patterns, this study aimed to explain typical COVID-19 CT patterns at tissue level.
METHODS
Eight autopsy cases were prospectively selected of patients with PCR-proven COVID-19 pneumonia with varying clinical manifestations and causes of death. All had been subjected to chest CT imaging 24-72 h prior to death. Twenty-seven lung areas with typical COVID-19 patterns and two radiologically unaffected pulmonary areas were correlated to histopathological findings in the same lung regions.
RESULTS
Two dominant radiological patterns were observed: ground-glass opacity (GGO) (n = 11) and consolidation (n = 16). In seven of 11 sampled areas of GGO, diffuse alveolar damage (DAD) was observed. In four areas of GGO, the histological pattern was vascular damage and thrombosis, with (n = 2) or without DAD (n = 2). DAD was also observed in five of 16 samples derived from areas of radiological consolidation. Seven areas of consolidation were based on a combination of DAD, vascular damage and thrombosis. In four areas of consolidation, bronchopneumonia was found. Unexpectedly, in samples from radiologically unaffected lung parenchyma, evidence was found of vascular damage and thrombosis.
CONCLUSION
In COVID-19, radiological findings of GGO and consolidation are mostly explained by DAD or a combination of DAD and vascular damage plus thrombosis. However, the different typical CT patterns in COVID-19 are not related to specific histopathological patterns. Microvascular damage and thrombosis are even encountered in the radiologically normal lung.

Identifiants

pubmed: 34159661
doi: 10.1111/resp.14101
pmc: PMC8447040
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

869-877

Subventions

Organisme : Amsterdam UMC Corona Research Funds
ID : 2007794

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.

Références

Am J Clin Pathol. 2020 May 5;153(6):725-733
pubmed: 32275742
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Ann Intern Med. 2020 Aug 18;173(4):268-277
pubmed: 32374815
AJR Am J Roentgenol. 2020 Oct;215(4):839-842
pubmed: 32298149
Lancet Respir Med. 2020 Jul;8(7):681-686
pubmed: 32473124
Respirology. 2021 Sep;26(9):869-877
pubmed: 34159661
Mod Pathol. 2020 Jun;33(6):1007-1014
pubmed: 32291399
Mod Pathol. 2020 Nov;33(11):2128-2138
pubmed: 32572155
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Br J Radiol. 2013 Jul;86(1027):20120614
pubmed: 23659926
AJR Am J Roentgenol. 1997 Feb;168(2):333-8
pubmed: 9016201
Histopathology. 2020 Oct;77(4):570-578
pubmed: 32542743
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
J Thorac Imaging. 2020 Jul;35(4):211-218
pubmed: 32427651
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Ann Transl Med. 2020 Aug;8(15):935
pubmed: 32953735
Radiology. 2008 Mar;246(3):697-722
pubmed: 18195376
Radiographics. 2013 Nov-Dec;33(7):1951-75
pubmed: 24224590
Radiology. 1993 Dec;189(3):693-8
pubmed: 8234692
Clin Imaging. 1996 Jan-Mar;20(1):1-7
pubmed: 8846301
J Thorac Dis. 2019 Jan;11(Suppl 1):S37-S44
pubmed: 30775026
Eur Radiol. 2020 Jun;30(6):3306-3309
pubmed: 32055945
Am Rev Respir Dis. 1982 Nov;126(5):887-92
pubmed: 7149455
Radiology. 2002 Oct;225(1):199-204
pubmed: 12355005
Radiology. 2020 Apr;295(1):18
pubmed: 32003646

Auteurs

Azar Kianzad (A)

Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Lilian J Meijboom (LJ)

Department of Radiology and Nuclear Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Esther J Nossent (EJ)

Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Eva Roos (E)

Department of Pathology, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Bernadette Schurink (B)

Department of Pathology, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Peter I Bonta (PI)

Department of Pulmonary Medicine, Amsterdam UMC, AMC, Amsterdam, The Netherlands.

Inge A H van den Berk (IAH)

Department of Radiology and Nuclear Medicine, Amsterdam UMC, AMC, Amsterdam, The Netherlands.

Rieneke Britstra (R)

Department of Pathology, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Jaap Stoker (J)

Department of Radiology and Nuclear Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Anton Vonk Noordegraaf (A)

Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Paul van der Valk (P)

Department of Pathology, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Erik Thunnissen (E)

Department of Pathology, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Marianna Bugiani (M)

Department of Pathology, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Harm Jan Bogaard (HJ)

Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Teodora Radonic (T)

Department of Pathology, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH